Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Castelli

Showing results (321-330 of 425) with videos related to

Pageof 43
Sort By:
AIDS Care|February 16, 2023
Does the rapid initiation of antiretroviral therapy at HIV diagnosis impact virological response in a real-life setting? A single-centre experience in Northern ItalyNatalia Gregori, Stefano Renzetti, Ilaria Izzo, et al.
Journal of Travel Medicine|February 11, 2004
Knowledge, attitudes and practices in travel-related infectious diseases: the European airport surveyKoen Van Herck, Pierre Van Damme, Francesco Castelli, et al.
Journal of Travel Medicine|April 26, 2012
Travel-associated illness in older adults (>60 y)Philippe Gautret, Jean Gaudart, Karin Leder, et al.
Journal of Translational Medicine|April 18, 2015
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort studyElena Raffetti, Francesco Donato, Filippo Castelnuovo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trialFrancesco Mazzotta, Sergio Lo Caputo, Carlo Torti, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2022
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwideFrancesca Caccuri, Serena Messali, Alberto Zani, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2016
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort studyEugenia Quiros-Roldan, Elena Raffetti, Francesco Castelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|April 21, 2022
Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated InfectionBenedetta Fumarola, Stefano Calza, Stefano Renzetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2015
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter StudyElena Raffetti, Francesco Donato, Chiara Pezzoli, et al.
BMC Public Health|August 26, 2016
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER CohortElena Raffetti, Maria Concetta Postorino, Francesco Castelli, et al.
Pageof 43

Showing results (321-330 of 425) with videos related to

Sort By:
Pageof 43
AIDS Care|February 16, 2023
Does the rapid initiation of antiretroviral therapy at HIV diagnosis impact virological response in a real-life setting? A single-centre experience in Northern ItalyNatalia Gregori, Stefano Renzetti, Ilaria Izzo, et al.
Journal of Travel Medicine|February 11, 2004
Knowledge, attitudes and practices in travel-related infectious diseases: the European airport surveyKoen Van Herck, Pierre Van Damme, Francesco Castelli, et al.
Journal of Travel Medicine|April 26, 2012
Travel-associated illness in older adults (>60 y)Philippe Gautret, Jean Gaudart, Karin Leder, et al.
Journal of Translational Medicine|April 18, 2015
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort studyElena Raffetti, Francesco Donato, Filippo Castelnuovo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trialFrancesco Mazzotta, Sergio Lo Caputo, Carlo Torti, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2022
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwideFrancesca Caccuri, Serena Messali, Alberto Zani, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2016
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort studyEugenia Quiros-Roldan, Elena Raffetti, Francesco Castelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|April 21, 2022
Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated InfectionBenedetta Fumarola, Stefano Calza, Stefano Renzetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2015
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter StudyElena Raffetti, Francesco Donato, Chiara Pezzoli, et al.
BMC Public Health|August 26, 2016
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER CohortElena Raffetti, Maria Concetta Postorino, Francesco Castelli, et al.
Pageof 43